20/20 Biolabs, Inc.
PricedNASDAQ Capital: AIDX
20/20 Biolabs, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Offering size
—
Exchange
NASDAQ Capital
Ticker: AIDX
Status
Priced
IPO date
Feb 19, 2026
IPO timeline
Upcoming
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Feb 19, 2026
First-day trading
Shares available on the open market.
Frequently asked questions
When is 20/20 Biolabs, Inc. going public?
20/20 Biolabs, Inc. has been priced and is expected to begin trading on Feb 19, 2026.
What is 20/20 Biolabs, Inc.'s IPO valuation?
20/20 Biolabs, Inc.'s IPO valuation has not been publicly disclosed. FireStrike will update this page when a price range or offering size is announced.
What exchange will 20/20 Biolabs, Inc. list on?
20/20 Biolabs, Inc. is expected to be listed on the NASDAQ Capital. The ticker symbol is AIDX.
Has 20/20 Biolabs, Inc. filed an S-1 with the SEC?
No. As of the most recent data, 20/20 Biolabs, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR